Insider: Burke Steven Keith SVP, Chief Medical Officer - Akebia Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 809,090 | 0 | 809,090 |
| Value | $2,216,906.60 | $0.00 | $2,216,906.60 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/03/2025 | DDS | 7,144 | Direct | COM | $1.83 | $13,073.52 | 809,090 |
| 02/03/2025 | DDS | 23,270 | Direct | COM | $2.10 | $48,867.00 | 843,470 |
| 02/03/2025 | DDS | 27,236 | Direct | COM | $2.10 | $57,195.60 | 816,234 |
| 02/29/2024 | DDS | 7,169 | Direct | COM | $1.58 | $11,327.02 | 695,840 |
| 02/27/2024 | DDS | 8,367 | Direct | COM | $1.52 | $12,717.84 | 703,009 |
| 02/01/2024 | DDS | 24,311 | Direct | COM | $1.68 | $40,842.48 | 711,376 |
| 08/25/2023 | DDS | 27,000 | Direct | COM | $1.15 | $31,050.00 | 668,840 |
| 05/16/2023 | DDS | 63,567 | Direct | COM | $1.07 | $67,889.56 | 530,487 |
| 03/01/2023 | DDS | 6,613 | Direct | COM | $0.88 | $5,802.91 | 601,564 |
| 03/01/2023 | DDS | 6,400 | Direct | COM | $0.88 | $5,616.00 | 595,164 |
| 03/01/2023 | DDS | 1,110 | Direct | COM | $0.88 | $974.03 | 594,054 |
| 02/27/2023 | DDS | 7,539 | Direct | COM | $0.81 | $6,130.71 | 608,177 |
| 08/31/2022 | DDS | 1,147 | Direct | COM | $0.36 | $415.79 | 418,016 |
| 03/01/2022 | DDS | 6,556 | Direct | COM | $2.17 | $14,231.11 | 217,263 |
| 03/01/2022 | DDS | 1,100 | Direct | COM | $2.17 | $2,387.77 | 217,663 |
| 02/28/2022 | DDS | 7,400 | Direct | COM | $2.15 | $15,945.52 | 163,819 |
| 08/31/2021 | DDS | 1,042 | Direct | COM | $2.83 | $2,948.86 | 171,219 |
| 04/01/2021 | DDS | 1,081 | Direct | COM | $3.40 | $3,675.40 | 170,761 |
| 03/01/2021 | DDS | 7,558 | Direct | COM | $3.40 | $25,667.72 | 161,442 |
| 11/20/2019 | AAP | 27,000 | Direct | COM | $3.58 | $96,660.00 | 37,000 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research